Over the last two decades, important contributions were made at national, European and international levels to foster collaboration
into rare diseases research.
Not exact matches
In new
research, scientists reprogrammed skin cells from patients with
rare blood disorders
into iPSCs, highlighting the great promise of these cells in advancing understanding of those challenging
diseases — and eventually in treating them.
The researchers are hoping that this breakthrough will give a fresh boost to
research into this
rare disease.
IRDiRC looks forward to welcoming more members, in particular from regions that are currently under - represented, ensuring their vital voice, experience and input are integrated
into global
rare diseases research agenda, bringing diagnostics and therapies to patients globally.
October 25, 2016 UChicago Medicine designated as first cavernous angioma center of excellence Angioma Alliance, the nation's only patient advocacy nonprofit for individuals impacted by cerebral cavernous angiomas, has designated the University of Chicago Medicine as its first Clinical Center of Excellence for treatment and
research into the
rare disease.
It is essential that cutting - edge genomic
research translates
into clinical care helping to understand the biology of
rare diseases.
Building initially on world - leading pre-clinical and clinical
research into epilepsy and motor neurone
disease, the FutureNeuro Centre is a scalable platform that will expand quickly to focus on other chronic and
rare neurological
diseases.
4/7/2008 From Bench to Bedside in One Year: Stem Cell
Research Leads to Potential New Therapy for
Rare Blood Disorder A unique partnership between industry and academia has led to human clinical trials of a new drug for a rare class of blood diseases called myeloproliferative disorders (MPD), which are all driven by the same genetic mutation and can evolve into leuk... Mor
Rare Blood Disorder A unique partnership between industry and academia has led to human clinical trials of a new drug for a
rare class of blood diseases called myeloproliferative disorders (MPD), which are all driven by the same genetic mutation and can evolve into leuk... Mor
rare class of blood
diseases called myeloproliferative disorders (MPD), which are all driven by the same genetic mutation and can evolve
into leuk... More...
Funded as part of the EU's commitment to the International
Rare Diseases Research Consortium (IRDiRC), RD - Connect is a global infrastructure project that links omics data with databases, registries, biobanks, and clinical bioinformatics tools into a central research resource for rare disea
Rare Diseases Research Consortium (IRDiRC), RD - Connect is a global infrastructure project that links omics data with databases, registries, biobanks, and clinical bioinformatics tools into a central research resource for rare d
Research Consortium (IRDiRC), RD - Connect is a global infrastructure project that links omics data with databases, registries, biobanks, and clinical bioinformatics tools
into a central
research resource for rare d
research resource for
rare disea
rare diseases.
Prothena, which is Patient Capital's third - biggest holding, announced that it was stopping further
research into its treatment for the
rare disease amyloidosis, prompting shares in the company to fall by 68 %.